Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors.
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors. Gastroenterology. 2018 03; 154(4):998-1008.e1.
View in:
PubMed
subject areas
Adult
Aged
Chi-Square Distribution
Disease Progression
Disease-Free Survival
Female
Gastrointestinal Neoplasms
Humans
Kaplan-Meier Estimate
Male
Maryland
Middle Aged
Multivariate Analysis
Neuroendocrine Tumors
Organometallic Compounds
Pancreatic Neoplasms
Positron Emission Tomography Computed Tomography
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Radiopharmaceuticals
Risk Factors
Time Factors
Tumor Burden
authors with profiles
Xavier Keutgen